Systemic infection with Escherichia coli significantly decreased feed intake, slowed growth of the whole body and skeletal muscles, and severely inhibited muscle protein accumulation in both chicks and rats. Treatment with naproxen (6-methoxy-a-methyl-2-naphthaleneacetic acid), an inhibitor of prostaglandin production, decreased weight losses of body and muscle, and significantly inhibited muscle protein wasting in infected chicks and rats. E. coli infection increased net protein degradation by 44.8 % (P < 0.05) and prostaglandin E2 production by 148 % (P < 0.05) in isolated extensor digitorum communis muscle from chicks on day 2 after infection. Naproxen treatment significantly decreased net protein degradation and prostaglandin E2 production in infected chicks to values seen in muscles of healthy controls. Quantitatively and qualitatively similar results were seen in isolated rat epitrochlearis muscle.
INTRODUCTION
A marked whole-body wasting and protein loss from skeletal muscle are characteristics ofinfection and various other pathological states [1] . Infectious disease leads to increased muscle breakdown, urinary nitrogen loss, and detectable losses of body protein [1, 2] . The relative importance of changes in muscle protein synthesis and degradation in muscle wasting during infection have been addressed by several authors [3] [4] [5] . Many hormones and factors have been thought to be involved in the regulation ofmuscle protein metabolism during infection, including insulin, glucagon, growth hormone, thyroid hormone, glucocorticoids [1] , and, more recently, prostaglandins [5] [6] [7] .
Prostaglandins (PGs) are cyclopentane derivatives formed from polyunsaturated fatty acids and released by most animal cells in response to a variety of physiological and pathological stimuli [8] . Recently, the possibility that prostaglandins might be important in the regulation of muscle protein turnover in normal or pathological conditions has come to light. Skeletal muscle in humans and rats can produce metabolites of arachidonic acid, including PGI2, thromboxane B2, PGE2 and PGF2a [9] [10] [11] . When added to muscles in vitro, PGE2 stimulated muscle protein degradation and PGF2, activated protein synthesis [11, 12] . For example, when rat muscles were treated with PGE2, protein synthesis was not affected, but protein degradation increased by about 22 % [11] . By contrast, PGF2. had no effect on protein degradation, but increased protein synthesis [10, 11] .
More recently, several authors have attempted to clarify the role of prostaglandins in the regulation of muscle protein turnover in vivo. For example, injection of live Escherichia coli into rats caused fever, and increased both PGE2 production and protein degradation in skeletal muscle [7] . When the rats were pre-treated with indomethacin, an inhibitor of prostaglandin production, the increased protein degradation and prostaglandin synthesis owing to infection were inhibited [7] . Indomethacin has also been reported to prevent muscle protein loss and impaired contractile force owing to S. pneumoniae infection [13] . These studies suggested that the rapid onset of muscle wasting that takes place during infection in vivo is signalled by a prostaglandin-dependent mechanism (7, 13] , although it remains unclear as to which stimulus might be responsible for enhanced PGE2 release. However, the role of PGE2 in regulation of muscle proteolysis is the subject of continuing controversy [14] [15] [16] [17] . Further evidence is therefore required to confirm whether PGE2 is important in regulation of muscle proteolysis. The objective of the study reported here was to test for a prostaglandin-dependent mechanism in muscle wasting induced by a systemic infection in two species: the broiler chick (Gallus domesticus) and laboratory rat (Rattus norvegicus), using an experimental E. coli infection technique previously developed in our laboratory (Tian & Baracos [17a] ).
EXPERIMENTAL

Experimental design
Chicks or rats were assigned to four treatment groups: control, infected, naproxen control, naproxen infected, such that the mean initial body weight and S.E.M. of each group were similar. All experiments used at least six animals per treatment, and experiments were repeated at least twice. For each animal allocated to a control treatment, two animals were allocated to be infected, because of anticipated mortality. Naproxen (6-methoxya-methyl-2-naphthaleneacetic acid) [18] was administered in the drinking water (1.6 mg/100 g body wt. per day). Preliminary experiments showed this was a minimum effective dose to block fever induced by the injection of E. coli endotoxin (V. E. Baracos, unpublished work to verify the ingestion of the naproxen-treated water. Addition of this agent did not affect the water consumption of treated rats or chicks. Since feed and water intake of infected subjects fell markedly, in those experiments where naproxen was administered after infection, this agent was injected intraperitoneally (1.6 mg/ 100 g body wt. 25 mM-NaHCO3, 1 .24 mM-NaHPO4, 1 .0 mMCaC12) containing 2 mM-Hepes/NaOH (pH 7.4) and 0.3 ,tg of chloramphenicol/ml. The medium was supplemented with glucose (chick muscle 15 mM; rat muscle 5 mM) and insulin (chick 0.1 unit/ml; rat 0.1 unit/ml). Muscles were incubated for 30 min at 36 0C, then transferred to fresh medium of the same composition and incubated for another 3 h. Rates of protein synthesis and degradation, and net degradation were determined as previously described [6, 20] . In this approach, the rate of protein synthesis is determined as the rate of incorporation of [3H]phenylalanine into tissue protein. Net protein degradation is determined as the rate of net phenylalanine release into the incubation medium. Protein degradation is calculated as the sum of rates of synthesis and net degradation. Incubated muscles are in negative protein balance, apparently owing to depressed rates of protein synthesis [20] . In our chick muscle preparation used here, this represents the net degradation of only 0.03 0 of total protein/h, and rates of protein synthesis compare favourably with those observed in vivo [20] . PGE2 production was estimated by radioimmunoassay of the incubation medium as described previously [6] . The cross-reactivity of the anti-PGE2 antibody (ICN Immunobiologicals) with PGE1 is 150 %0, but with PGF2a less than 20%. Since skeletal muscle is not known to synthesize PGE1 [9] , this cross-reactivity would not appear to pose a problem for the determination of PGE2. The effective range of the assay was 12.5-875 pg/sample.
Data analysis
Results are expressed as means + standard error of the group mean. The results were analysed with one-way analysis of variance.
RESULTS
Initially, control experiments were carried out to assess the effects of naproxen on growing Sprague-Dawley rats (Table 1) . This agent had no significant effect on feed intake, faecal and urinary nitrogen losses, and muscle protein content, when administered for a period of 5 days in the drinking water. In addition, naproxen had no effect on protein synthesis or degradation determined in isolated epitrochlearis muscle (results not shown). In addition, naproxen administered to healthy rats and chicks had no significant effect on growth, feed intake or muscle protein metabolism (see below).
Effect of naproxen administration before infection
In order to test whether prostaglandins might be involved in signalling muscle protein catabolism after infection, animals were infected under conditions of naproxen pretreatment. The data shown in Figs. 1 and 2  and Tables 2-5 are from experiments where naproxen was administered from 24 h before infection. Whole-body and muscle growth Healthy young broiler chicks and naproxen-treated control chicks showed rapid rates of growth during the experimental period. After injection of E. coli, the growth of infected chicks continued at a low rate, such that the body-weight gain of infected birds was less than that of controls by 59 %/ (P < 0.05) on day 2 after injection (Table 2) . Rats grew more slowly than chicks, and E. coli injection significantly decreased the body weight in rats over a 2-day interval after infection (P < 0.05) ( Table 2 ). The administration of naproxen alone had no effect on the body-weight gain of rats or chicks. The body-weight gain of infected chicks or rats treated with naproxen was significantly improved compared with infected subjects ( Table 2) .
As shown in Table 3 , the weights of two different muscles in the chicks were decreased on day 2 after infection. The weights of EDC and sartorius muscles were depressed by 22.6 o and 29.30 (P < 0.05) ( Table  3) ; at the same time body weight was decreased by 170 (Table 2 ). In the rats, E. coli injection decreased muscle weight by 1 1.20 (NS) in soleus and by I0 % (P < 0.05) in EDL (Table 3) ; these changes were similar to the depression in whole body weight (-10.2 0%). Naproxen alone had no effect on muscle weight; however, naproxentreated infected subjects had muscle weights which were intermediate between those of control and infected subjects (P > 0.05). Protein content Table 4 depicts the protein content of muscles shown in Table 3 . The total protein content and percentage protein of the muscles were significantly lower than those of healthy controls in both infected chicks and rats. The changes in total protein contents seen in muscles of infected birds and rats were more dramatic than the changes in muscle weight (Tables 3 and 4) . Total muscle protein was depressed by E. coli injection by 37.20% (P < 0.05) in chick EDC muscle, 53.8 o (P < 0.05) in chick sartorius, 46.4 % (P < 0.05) in rat EDL, and 23.7 o (P < 0.05) in rat soleus. This was associated with a decrease in muscle protein content/g of tissue, which was depressed (P < 0.05, n = 7) in all muscles tested (EDC -18%, sartorius -36 %, soleus -13 %, EDL -40°% ). Naproxen alone had no significant effect on total muscle protein or protein content/g wet wt. Broiler chicks were housed in battery cages, 10-22 birds/pen. Feed intake ad libitum for each group was determined daily. Chicks were fed on broiler starter ration containing 23.3% crude protein and 11700 kJ (2795 kcal) of metabolizable energy/kg. Values given represent averages for a group (pen) of birds. Chicks were injected with E. coli (3 x 101 colony-forming units/kg body wt.) or saline. Naproxen was offered in the drinking water from the day before infection. Group: U, control; E, infected; L, naproxen control; E, infected + naproxen.
response to infection was inhibited by 57 % and 71 % (P < 0.05) respectively. In general a greater degree of inhibition was seen in the oxidative rat soleus and chick sartorius than in the glycolytic EDC and EDL muscles. PGE2 production and net protein degradation Table 5 shows net protein degradation and PGE2 production in isolated chick EDC muscle and rat epitrochlearis muscle. Infected animals showed increased rates (P < 0.05) of net protein degradation (+44.8% in chicks; +32.6% in rats) and PGE2 production (+148% in chicks; + 156% in rats) on day 2 after injection. Naproxen alone had no significant effect on either basal PGE2 production or net protein degradation in either chicks or rats. However, naproxen treatment significantly (P < 0.05) inhibited PGE2 production and net protein degradation in muscles from infected chicks, to values seen in healthy controls (Table   5 ). Neither infection nor naproxen had any detectable effect on protein synthesis in rat epitrochlearis muscle, suggesting that increased rates of protein degradation Table 6 . Effect of naproxen treatment at 24 h after infection on muscle content in E. coli-infected chicks Chicks are injected with E. coli (3 x 109 colony-forming units/kg body wt.) or saline. Naproxen was injected intraperitoneally at 12 h after infection; thereafter naproxen was offered in the drinking water. Muscles were dissected 2 days after infection. abc Means within in a column not sharing a common superscript are significantly different, P < 0.05 (n > 7).
Muscle total protein (mg) Fig. 2 . Effect of naproxen pretreatment on feed intake during E. coli infection in rats Rats were housed in individual cages. Feed intake ad libitum for each rat was determined daily. Rats were fed on laboratory chow containing 24 % crude protein. Means within a day not sharing a common superscript are different (P < 0.5; n > 7). Rats were injected with E. coli (3 x I0O colony-forming units/kg body wt.) or saline. Naproxen was offered in the drinking water from the day before infection. may be primarily responsible for the net catabolism of muscle in infected rats.
Feed intake
Feed intake of healthy control chicks and rats was constant during 3 days of the study. Feed intake of infected birds was depressed by 36 % on day 1 and by 42 % on day 2 after infection ( Fig. 1) . Feed intake of infected rats was depressed by 64 % on day 1 and by 48 % on day 2 after infection (P < 0.05) (Fig. 2) . Naproxen pretreatment had no significant effect on feed intake in either healthy or infected chicks or rats.
Effect of naproxen administration after infection
To determine whether naproxen might influence muscle wasting after this process had already been initiated, a series of experiments was conducted where naproxen was administered 6 or 24 h after E. coli. When infected chicks were treated with naproxen after infection, the effect of naproxen treatment was qualitatively similar to the effect of naproxen adminstrated after infection (see above). Naproxen treatment after infection improved body weight and muscle tissue weight measured 4 
days
Vol. 263 after infection. As illustrated in Table 6 , naproxen treatment at 24 h after infection increased the protein content of sartorius muscles (P < 0.05) and EDC muscles (NS), compared with infected birds.
DISCUSSION
Protein balance of the whole body and of individual tissues is dictated by the relative rates of protein synthesis and degradation. In catabolic states such as infection, many factors have been suggested to activate the net catabolism of skeletal muscle, including circulating hormones, depressed feed intake, inactivity, and factors associated with host defence responses [1] . It remains to be clarified whether, or when, each of these factors is of importance. Our recent work has concentrated on the role of factors originating from mononuclear phagocytes in muscle catabolism, including lymphokines and prostaglandins [5, 6] . The present results support the suggestion that prostaglandins might be important in regulation of muscle protein turnover [6, 7, [10] [11] [12] [13] 21] and identify their function in two species.
Naproxen is an inhibitor of prostaglandin biosynthesis [18] . In the present study, naproxen administered at a minimum effective dose had no effect on protein balance or muscle protein metabolism in healthy individuals. PGE2 production by muscles of infected chicks or rats was elevated, as reported by others [7, 16] . The administration of naproxen decreased this enhanced PGE2 production to values seen in healthy controls.
Under conditions of naproxen pretreatment, inhibition of PGE2 production was associated with a significant decrease in body weight loss and muscle protein loss owing to infection. The increased net protein degradation observed in both incubated chick and rat muscles was also abolished by naproxen pretreatment. When naproxen was administered after infection, similar results were observed, although the degree of improvement was less. These results suggest that prostaglandins may be important for the initiation and maintenance of muscle catabolism.
Our results agree with those of Fagan & Goldberg [7] , who treated rats with indomethacin before injection of E. coli or E. coli endotoxin, and observed decreased PGE2 production and net protein degradation in rat muscle in vitro. Ruff & Secrist [13] similarly treated rats with indomethacin before injection of S. pneumoniae, and prevented the loss of muscle protein and contractile force after infection. The results of the present study and those cited above do not agree with those of Hasselgren et al. [14, 15] . In their experiments, indomethacin administered in vitro partially inhibited PGE2 production, but did not significantly decrease accelerated protein degradation in muscles of septic rats. Several possible explanations arise for this discrepancy from the present results. The addition of indomethacin (3 /tM) to incubation medium decreased PGE2 production weakly, by only 200 in controls and by 500 in muscles of septic rats [14] . This is in contrast with our observations [6] and those of Rodemann & Goldberg [11] , where indomethacin abolished PGE2 production in vitro at low concentrations (2.8 /M). Since indomethacin is extremely insoluble, one possibility is that in the studies of Hasselgren et al. [14,151 this agent was not solubilized at an effective concentration. In addition, if addition of indomethacin could influence protein degradation only after a time lag of several hours, an effect of indomethacin might not be evident during a 2 h incubation. A further complicating factor is that cycloheximide (0.5 /tM) was used in the muscle incubations in vitro by Hasselgren et al. [14, 15] to inhibit protein synthesis; this allows direct determination of rates of protein degradation. This agent has been found to inhibit muscle PGE2 production [22] . Since 700 inhibition of PGE2 production can be demonstrated in the presence of 1 /iM-cycloheximide [22] , it seems unlikely that Hasselgren et al. [14, 15] would have been able to observe prostaglandin-dependent muscle protein catabolism in their system. The same authors also treated rats with indomethacin (3 mg/kg) in vivo, 45 min before induction of sepsis and again after 3 h [14] . Since they did not report whether indomethacin had achieved an effective concentration in vivo, these results are difficult to interpret. When Fagan & Goldberg [7] treated rats with indomethacin after injection of E. coli endotoxin, the increased net proteolysis was not affected, although the augmented PGE. production of muscles was clearly abolished. The reason for this discrepancy with our results is not clear; this point requires further investigation.
The involvement of prostaglandins in regulation of muscle protein turnover requires further study. It is not clear whether muscle tissue is the major source of PGE2 in infected animals, or whether cells such as activated mononuclear phagocytes make a significant contribution. Although the action of PGE2 on muscle may be direct, inhibition of prostaglandin synthesis systemically might indirectly influence muscle catabolism. For example, naproxen treatment would inhibit fever, and the elevated metabolic energy expenditure associated with it [23] . This would serve to lower the net use of muscle protein as a metabolic fuel. It Baracos, unpublished work) . Finally, since inhibition of prostaglandin synthesis did not entirely block weight and protein loss associated with infection, further effort is required to determine the underlying basis of the naproxen-insensitive protein degradation. For example, the muscle wasting seen here may be related, to some extent, to the large and rapid fall in voluntary feed intake by infected chicks and rats.
